O'Neill Gilmore Neil
Insider CIK 1742084 · UBX Director · EDIT CEO, Director · APTX Director · SRPT SVP & Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EDIT Editas Medicine, Inc. | S Sale | 2026-09-03 | 2026-09-04 | 5,124 | $3.04 | $15.6K | 243,189 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2026-09-03 | 2026-09-04 | 5,124 | $3.04 | $15.6K | 243,189 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2026-06-03 | 2026-06-05 | 15,380 | $2.70 | $41.5K | 248,313 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2026-03-12 | 2026-03-16 | 1,015,200 | — | $0 | 1,015,200 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2026-03-03 | 2026-03-04 | 5,394 | $2.02 | $10.9K | 263,693 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2025-12-03 | 2025-12-04 | 5,603 | $2.15 | $12.0K | 269,087 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2025-09-03 | 2025-09-04 | 5,592 | $2.60 | $14.5K | 274,690 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2025-06-03 | 2025-06-04 | 15,192 | $1.72 | $26.1K | 280,282 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2025-03-08 | 2025-03-27 | 828,000 | — | $0 | 828,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2025-03-08 | 2025-03-27 | 175,000 | — | $0 | 175,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2025-03-04 | 2025-03-05 | 16,632 | $1.71 | $28.4K | 295,474 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2024-12-03 | 2024-12-05 | 1,618 | $2.08 | $3.4K | 312,106 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2024-09-04 | 2024-09-06 | 1,555 | $3.42 | $5.3K | 313,724 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2024-06-21 | 2024-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2024-06-04 | 2024-06-06 | 12,191 | $5.50 | $67.1K | 315,279 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2024-03-05 | 2024-03-05 | 77,824 | $9.42 | $733.1K | 327,470 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2024-03-02 | 2024-03-05 | 392,100 | — | $0 | 392,100 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2024-03-02 | 2024-03-05 | 130,700 | — | $0 | 260,869 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2024-03-02 | 2024-03-05 | 72,213 | — | $0 | 333,082 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2024-03-02 | 2024-03-05 | 72,212 | — | $0 | 405,294 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2023-06-23 | 2023-06-26 | 6,000 | — | $0 | 6,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | S Sale | 2023-06-05 | 2023-06-07 | 6,486 | $9.50 | $61.6K | 130,169 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2023-03-02 | 2023-03-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2023-03-02 | 2023-03-06 | 50,000 | — | $0 | 136,655 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2022-06-24 | 2022-06-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 950,209 | — | $0 | 950,209 | SEC↗ |
| EDIT Editas Medicine, Inc. | A Award | 2022-06-02 | 2022-06-06 | 86,655 | — | $0 | 86,655 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2022-05-26 | 2022-05-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| APTX Aptinyx Inc. | A Award deriv | 2021-10-19 | 2021-10-22 | 80,000 | — | $0 | 80,000 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2021-06-24 | 2021-06-28 | 13,425 | — | $0 | 13,425 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2021-03-03 | 2021-03-05 | 60,000 | — | $0 | 60,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2021-03-03 | 2021-03-05 | 15,000 | — | $0 | 29,070 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2021-03-03 | 2021-03-10 | 15,000 | — | $0 | 28,546 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2021-02-28 | 2021-03-10 | 524 | $86.97 | $45.6K | 13,546 | SEC↗ |
| UBX Unity Biotechnology, Inc. | A Award deriv | 2020-12-10 | 2020-12-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2020-02-28 | 2020-02-28 | 37,500 | — | $0 | 37,500 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award | 2020-02-28 | 2020-02-28 | 6,700 | — | $0 | 14,070 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | F Tax w/h | 2019-05-24 | 2019-05-24 | 4,630 | $119.31 | $552.4K | 7,370 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise deriv | 2019-05-23 | 2019-05-24 | 12,000 | — | $0 | 0 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | M Exercise | 2019-05-23 | 2019-05-24 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2019-03-04 | 2019-03-04 | 55,000 | — | $0 | 55,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2018-06-07 | 2018-06-11 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SRPT Sarepta Therapeutics, Inc. | A Award deriv | 2018-06-07 | 2018-06-11 | 100,000 | — | $0 | 100,000 | SEC↗ |